#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypomagnesaemia Andersen-Tawil syndrome Autoinflammation with infantile enterocolitis Lymphangioma Acute graft versus host disease in liver Atopic keratoconjunctivitis Hypophosphatasia Adrenogenital syndrome Palmar-plantar erythrodysaesthesia syndrome Ewing's sarcoma Biotinidase deficiency Glycogen storage disease type I Netherton's syndrome Glomerulonephritis membranous Pancreatic carcinoma More trials…

    Learn about Rare Diseases

    Congenital generalised lipodystrophy – Trials in Disease Familial amyotrophic lateral sclerosis Angiosarcoma recurrent – Life with Disease Congenital nephrogenic diabetes insipidus – Trials in Disease Cystic fibrosis lung – Basic Information Langerhans’ cell histiocytosis – Diagnostics X-linked lymphoproliferative syndrome Krabbe’s disease – Treatment Von Willebrand’s disease – Life with Disease Hereditary ataxia – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bms-986288 Tianeptine A/(H3N2)-LIKE VIRUS ANTIGEN T89 Incb000928 Trastuzumab Doxycycline Monohydrate Solifenacin Succinate Degarelix SONLICROMANOL HYDROCHLORIDE Etrinabdione Sufentanil Atropine Sulfate Monohydrate Odronextamab Gs-1427 Somapacitan Gskvx000000014593 Gandotinib Afatinib Cenerimod More therapies…

    Learn about Your Condition

    Adenocarcinoma pancreas Vaginal cancer Ophthalmoplegia Pancreaticoduodenectomy Pruritus Agitation Cutaneous sarcoidosis Angelman's syndrome Seizure Obliterative bronchiolitis Cervix carcinoma stage IV Rheumatic disorder Asplenia Pouchitis Orthostatic hypotension More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study Comparing Clarithromycin and Azithromycin for Treating Mycobacterium Avium Complex Lung Infections in Adults

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Mycobacterium avium complex infection
    Investigated Drugs:
    • Azithromycin
    • Clarithromycin
    • Ethambutol Hydrochloride
    France

  • Study of dexpanthenol mouth rinse for preventing radiation-induced oral mucositis in patients receiving radiotherapy

    Recruiting

    3 1 1
    Investigated Drugs:
    • Dexpanthenol
    Germany

  • Study on Upadacitinib for Patients with Idiopathic Inflammatory Myopathies After Stopping IVIG

    Recruiting

    2 1 1
    Investigated Diseases:
    • Antisynthetase syndrome
    • Necrotising myositis
    • Polymyositis
    Investigated Drugs:
    • Upadacitinib
    Austria

  • Study of Carboplatin, Paclitaxel, and Cetuximab for Patients with Recurrent or Metastatic Head and Neck Cancer After Pembrolizumab Treatment Failure

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Carboplatin
    • Cetuximab
    • Paclitaxel
    France

  • Comparison of hydrocortisone and dexamethasone eye drops for treating inflammatory conjunctival secretions in patients with ocular prostheses

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Povidone
    • Hydrocortisone Sodium Phosphate
    • Dexamethasone Phosphate
    France

  • Study on the Effectiveness of Gemcitabine Hydrochloride for Patients with Low Grade Bladder Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Gemcitabine Hydrochloride
    Austria
Previous Page
1 … 396 397 398 399 400 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!